Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
17
days
The Evolution of Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma: Past Achievements, Current Standards, and Future Perspectives
Authors
Naoto Ujiie; Yusuke Taniyama; Chiaki Sato; Hiroshi Okamoto; Yohei Ozawa; Hirotaka Ishida; Michiaki Unno; Takashi KameiShow moreShow less
Affiliations
1. Department of Surgery, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Miyagi, JapanShow moreShow less
24
days
Parenchyma-Sparing Strategy in Central Non-Small Cell Lung Cancer: An Institutional Experience on Surgical Selection, Complications, and Survival
Authors
Cornel Florentin Savu; Andrei Cristian Bobocea; Amir-Andrei Sabha; Camelia-Alexandra Paruschi; Alina-Elena Tucana; Antoaneta Pungă; Silviu Gabriel VlăsceanuShow moreShow less
Affiliations
1. Thoracic Surgery I, University of Medicine and Pharmacy “Carol Davila”, 020021 Bucharest, Romania; 2. Department of Thoracic Surgery, “Marius Nasta” National Institute of Pneumology, 050150 Bucharest, Romania; 3. Medical Physiology Discipline, Functional Sciences Department, Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, 020021 Bucharest, RomaniaShow moreShow less
31
days
Feasibility Is Not Benefit: Resectable, Irradiable, or Biologically Selected? A Critical Review of the Unresolved Local-Platform Question in Stage III/N2 NSCLC
Authors
Panteleimonas Skarlos; Ioannis Georgakopoulos; Andromachi Kougioumtzopoulou; Zoi Liakouli; Kiki Theodorou; Anna Zygogianni; Emmanouil Georgiannakis; Vasileios Kouloulias; George MaravelisShow moreShow less
Affiliations
1. Department of Radiation Oncology, University Hospital of Larissa, Medical School, University of Thessaly, 41110 Larissa, Greece; 2. Radiation Oncology Department, ARETAIEION University Hospital, Medical School, Kapodistrian University of Athens, 11528 Athens, Greece; 3. Department of Clinical Radiation Oncology, University Hospital ATTIKON, Medical School, Kapodistrian University of Athens, 12462 Athens, Greece; 4. Department of Medical Physics, University Hospital of Larissa, Medical School, University of Thessaly, 41110 Larissa, Greece; 5. Department of Minimally Invasive Thoracic Surgery, Metropolitan Hospital, 18547 Piraeus, Greece; 6. Department of Thoracic Surgery, Metropolitan General, 15562 Athens, Greece; 7. Department of Basic and Clinical Sciences, Medical School, University of Nicosia (UNIC), Athens Campus, 16777 Athens, Greece; 8. 2nd Department of Radiation Oncology, Metropolitan Hospital, Neo Faliro, 18547 Piraeus, GreeceShow moreShow less
52
days
Molecular Biomarker Testing in Kidney Cancer: Integrating Diagnosis, Prediction, and Emerging Renal Tumor Entities
Authors
Busra Yaprak Bayrak; Elif Ozsagir; Nazif Alperen Yıldırım; Kerem Teke; Michael Cheng; Anna Caliò; Guido Martignoni; Mahmut Akgul; Liang ChengShow moreShow less
Affiliations
1. Department of Pathology, School of Medicine, Kocaeli University, Kocaeli 41001, Turkey; 2. Department of Pathology, Gulhane Research and Training Hospital, Ankara 06010, Turkey; 3. Department of Urology, School of Medicine, Kocaeli University, Kocaeli 41001, Turkey; 4. Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA; 5. Section of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy; 6. Department of Pathology, Pederzoli Hospital, 37019 Peschiera, Italy; 7. Department of Pathology, School of Medicine, Atlas University, Istanbul 34408, Turkey; 8. Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA; 9. Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI 02912, USAShow moreShow less
26
days
Integrated Transcriptomic Analysis Reveals Coordinated Gliovascular Remodeling Across Diffuse Glioma Grades
Authors
JuliAnne E. Allgood; Kaitlyn Miller; Lindsey Burnsed; Jessica E. PullanShow moreShow less
Affiliations
1. College of Osteopathic Medicine, Rocky Vista University, Ivins, UT 84738, USA; 2. Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USAShow moreShow less
30
days
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy
Authors
Linda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza RimassaShow moreShow less
Affiliations
1. Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; 2. IRCCS San Raffaele Hospital, 20132 Milan, Italy; 3. Vita-Salute San Raffaele University, 20132 Milan, Italy; 4. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan; 5. Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA; 6. Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy; 7. Clinical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy; 8. Department of Experimental and Clinical Medicine, University of Florence, 50139 Florence, Italy; 9. Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam 13620, Republic of Korea; 10. Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, 30625 Hannover, Germany; 11. Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Schwartz Reisman Liver Research Centre, Toronto ON M5G 2C4, Canada; 12. Department of Medical Oncology, FJD Comprehensive Cancer Centre, ENETS Centre of Excellence (GEP and Lung)—Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain; 13. Fundación Jiménez Díaz University Hospital, Health Research Institute Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain; 14. Oncology 1 Unit, Department of Medical Oncology, Veneto Institute of Oncology IOV—IRCCS, 35128 Padua, Italy; 15. Hepatopancreatobiliary Oncology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy; 16. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56124 Pisa, Italy; 17. Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy; 18. Digestive Oncology, University Hospitals Leuven, 3000 Leuven, Belgium; 19. School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK; 20. Beatson West of Scotland Centre, Glasgow G12 0YN, UK; 21. CRUK Scotland Centre, Glasgow G61 1BD, UK; 22. Department of Surgery&Cancer, Imperial College London, Hammersmith Hospital, London W12 0NN, UK; 23. Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, 73039 Tricase, Italy; 24. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; 25. Santa Maria Delle Croci Hospital of Ravenna, AUSL Romagna, 48121 Ravenna, Italy; 26. Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy; 27. Upper Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, 08035 Barcelona, Spain; 28. UOC Oncologia A, Department of Hematology, Oncology and Dermatology, Policlinico Umberto I, Sapienza University of Rome, 04019 Rome, Italy; 29. Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica Delle Marche, Azienda Ospedaliero-Universitaria Delle Marche, 60126 Ancona, Italy; 30. Digestive Unit, Champalimaud Clinical Centre, Champalimaud Research Centre Champalimaud Foundation, 1400-038 Lisbon, Portugal; 31. Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea; 32. Department of Medical Oncology, OECI Comprehensive Cancer Centre—ENETS Centre of Excellence (GEP and Lung)—Fundacion Jimenez Diaz University Hospital, Health Research Institute Fundación Jiménez Díaz (IIS-FJD), 28040 Madrid, Spain; 33. Medical Oncology and Biomedical Therapy, Policlinico Riuniti, 71122 Foggia, Italy; 34. Medical Clinic 1, University Hospital, Goethe-University Frankfurt, 60590 Frankfurt am Main, Germany; 35. Dipartimento di Oncologia medica, Fondazione Poliambulanza, 25124 Brescia, Italy; 36. Clinical Experimental Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, 80131 Naples, Italy; 37. IRCCS Istituto Nazionale Tumori Regina Elena, 00138 Roma, Italy; 38. Internal Medicine 1, University Hospital Ulm, 89081 Ulm, Germany; 39. Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, 89081 Ulm, Germany; 40. Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea; 41. Oncologia Medica, Dipartimento di Medicina dei Sistemi, Università di Tor Vergata, 00133 Roma, Italy; 42. Department of Medical Oncology, Unidade Local de Saude do Algarve (ULSAlg), 8000-286 Faro, Portugal; 43. Medical Oncology Unit, University Hospital of Parma, Parma 43126, Italy; 44. Oncology Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; 45. Department of Internal Medicine and Medical Therapy, University of Pavia, 27100 Pavia, Italy; 46. Division of Medical Oncology, Candiolo Cancer Institute IRCCS, 10060 Turin, Italy; 47. Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, 10043 Turin, Italy; 48. Medical Oncology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy; 49. Oncology Unit, Ospedale del Mare, 80147 Napoli, Italy; 50. ASAN Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea; 51. Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, 01100 Viterbo, Italy; 52. Oncology Unit, Fondazione IRCCS “Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy; 53. Medical Oncology, University Hospital and University of Cagliari, 09042 Cagliari, Italy; 54. GI Oncology Unit and Familial Cancer Unit, Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain; 55. Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; 56. Department of Medicine I, Clinical Division of Oncology, Medical University Vienna, 1090 Vienna, Austria; 57. Department of Medical Oncology, AULSS 8 Berica, 36110 Vicenza, Italy; 58. UOC Oncologia Territoriale, Polo Pontino, La Sapienza Università Di Roma, 04100 Latina, Italy; 59. National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan; 60. Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan; 61. Department of Clinical Oncology, Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong SAR, China; 62. Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK; 63. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, ItalyShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
